Orion Corporation (pharmaceutical company)
Company type | Julkinen osakeyhtiö |
---|---|
Nasdaq Helsinki: ORNBV | |
Industry | Pharmaceutical industry |
Founded | 1917 |
Headquarters | Espoo, Finland |
Key people | Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman) |
Products | Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests |
Revenue | €1006.9 million (2013)[1] |
€267.7 million (2013)[2] | |
€206.2 million (2013)[3] | |
Total assets | €979.0 million (2013)[4] |
Total equity | €513.9 million (2013)[5] |
Number of employees | 3,519 (2013)[6] |
Website | www.orion.fi |
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.
Orion's class A and B shares are listed on the Helsinki Stock Exchange.
Products
|
References
- ^ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ^ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ^ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ^ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ^ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
- ^ http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/
External links